Immuno-oncology research focuses on how the immune system recognises, responds to and is regulated by tumours. Sequencing and multi-omics technologies can help researchers investigate tumour–immune interactions, immune cell states, inflammatory signalling and mechanisms linked to immune escape or treatment response.
From bulk tumour profiling to single-cell and spatial analysis, omics-based approaches can support studies of the tumour immune microenvironment at multiple levels. These insights can help researchers explore immune infiltration, checkpoint-related pathways, antigen presentation, immune suppression and response-associated molecular features.
Novogene Europe supports immuno-oncology research with sequencing, single-cell, spatial and bioinformatics workflows for studies of tumour immune environments, therapy response, resistance mechanisms and biomarker discovery.
Common Research Approaches
Characterise immune and stromal cell populations, inflammatory signalling and immune-suppressive features within complex tumour research samples.
Study molecular patterns associated with response, non-response, immune escape and treatment-driven changes across research cohorts or models.
Resolve immune cell subsets, activation states, exhaustion programmes and cellular heterogeneity within complex tumour microenvironments.
Explore how immune cells, tumour regions and stromal compartments are organised across tissue and local niche environments.
We provide access to sequencing, single-cell, spatial and bioinformatics workflows to support immuno-oncology studies across tumour profiling, immune landscape analysis and tumour microenvironment research.
Depending on your study design, our team can help you consider suitable approaches for tumour tissue, blood-derived immune cells, cell models, preclinical samples or translational research cohorts.
Immuno-oncology research focuses on how the immune system recognises, responds to and is regulated by tumours. Sequencing and multi-omics technologies can help researchers investigate tumour–immune interactions, immune cell states, inflammatory signalling and mechanisms linked to immune escape or treatment response.
From bulk tumour profiling to single-cell and spatial analysis, omics-based approaches can support studies of the tumour immune microenvironment at multiple levels. These insights can help researchers explore immune infiltration, checkpoint-related pathways, antigen presentation, immune suppression and response-associated molecular features.
Novogene Europe supports immuno-oncology research with sequencing, single-cell, spatial and bioinformatics workflows for studies of tumour immune environments, therapy response, resistance mechanisms and biomarker discovery.
Common Research Approaches
Characterise immune and stromal cell populations, inflammatory signalling and immune-suppressive features within complex tumour research samples.
Study molecular patterns associated with response, non-response, immune escape and treatment-driven changes across research cohorts or models.
Resolve immune cell subsets, activation states, exhaustion programmes and cellular heterogeneity within complex tumour microenvironments.
Explore how immune cells, tumour regions and stromal compartments are organised across tissue and local niche environments.
We provide access to sequencing, single-cell, spatial and bioinformatics workflows to support immuno-oncology studies across tumour profiling, immune landscape analysis and tumour microenvironment research.
Depending on your study design, our team can help you consider suitable approaches for tumour tissue, blood-derived immune cells, cell models, preclinical samples or translational research cohorts.
